AI blood assay detects liver cancer across diverse international populations

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and uncovered the underlying biological signals that make the test effective.

• Published date: 31-07-2026 03:00 PM